Capital Research & Management Co recently announced the acquisition of new stake in Agilon Health Inc (NYSE:AGL). The institutional investor has increased its shareholding in the Healthcare company by 0.11% to 51.41 million shares with purchase of 57682.0 shares. This fresh investment now brings its stake to 12.66% valued currently at $545.92 million. In addition, Morgan Stanley Investment Managem raised its holdings by 3.53 million to 43.18 million shares. And Wellington Management Co. LLP has lifted its position by 8.29% or 3.16 million shares – to 41.32 million shares.
With over 13.44 million Agilon Health Inc (AGL) shares trading Monday and a closing price of $9.18 on the day, the dollar volume was approximately $123.37 million. The shares have shown a negative half year performance of -46.84% and its price on 01/08/24 gained nearly 6.37%. Currently, there are 412.38M common shares owned by the public and among those 300.38M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 115 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, accounting for 1,229,675 shares. Insider sales of the common stock occurred on 54 occasions, with total insider shares sold totaling 95,561,787 shares.
The top 3 mutual fund holders in Agilon Health Inc are American Funds New Economy Fund, Vanguard Health Care Fund, and American Funds AMCAP Fund. American Funds New Economy Fund owns 19.87 million shares of the company’s stock, all valued at over $211.07 million. The company bought an additional 0.1 million shares recently to bring their total holdings to about 4.89% of the shares outstanding. American Funds AMCAP Fund bought 3.7 million shares to bring its total holdings to over 17.05 million shares at a value of $181.09 million. American Funds AMCAP Fund now owns shares totaling to 4.20% of the shares outstanding.
Shares of Agilon Health Inc (NYSE: AGL) opened at $8.38, down -$0.25 from a prior closing price of $8.63. However, the script later moved the day high at 9.26, up 6.37%. The company’s stock has a 5-day price change of -26.85% and -49.75% over the past three months. AGL shares are trading -26.85% year to date (YTD), with the 12-month market performance down to -42.12% lower. It has a 12-month low price of $7.59 and touched a high of $29.44 over the same period. AGL has an average intraday trading volume of 3.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -25.07%, -28.41%, and -50.44% respectively.
Institutional ownership of Agilon Health Inc (NYSE: AGL) shares accounts for 86.93% of the company’s 412.38M shares outstanding. Mutual fund holders own 49.26%, while other institutional holders and individual stakeholders account for 68.46% and 18.52% respectively.
It has a market capitalization of $3.73B and a beta (3y monthly) value of 0.60. The earnings-per-share (ttm) stands at -$0.22. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.90% over the week and 5.61% over the month.
Analysts forecast that Agilon Health Inc (AGL) will achieve an EPS of -$0.15 for the current quarter, $0.06 for the next quarter and $0.01 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.28 while analysts give the company a high EPS estimate of -$0.09. Comparatively, EPS for the current quarter was -$0.14 a year ago. Earnings per share for the fiscal year are expected to decrease by -10.14%, and 81.92% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 17 brokerage firm advisors rate Agilon Health Inc (AGL) as a “Strong Buy” at a consensus score of 1.94. Specifically, 9 Wall Street analysts polled rate the stock as a buy, while 8 of the 17 advise that investors “hold,” and 0 rated it as a “Sell.”
